Table 3 |
||||
|
Outcomes meeting ACR 20 criteria by treatment group |
||||
|
Bacillus coagulans GBI-30, 6086 |
Placebo |
|||
|
|
||||
|
% Change |
Met ACR 20 Criteria? |
% Change |
Met ACR 20 Criteria? |
|
|
|
||||
|
Total painful joints |
-29.9 |
Yes |
-29.3 |
Yes |
|
|
||||
|
Total swollen joints |
-17.0 |
No |
-19.3 |
No |
|
|
||||
|
Patient global |
-11.7 |
No |
-1.5 |
No |
|
|
||||
|
Patient pain |
-19.8 |
No |
-1.6 |
No |
|
|
||||
|
Patient disability |
-22.5 |
Yes |
-2.2 |
No |
|
|
||||
|
Physician global |
-21.6 |
Yes |
-22.3 |
Yes |
|
|
||||
|
CRP/ESR |
-46.0/+6.5 |
Yes |
+4.8/+9.1 |
No |
|
|
||||
|
ACR = American College of Rheumatology. ESR = erythrocyte sedimentation rate. CRP = C-reactive protein. |
||||
|
Mandel et al. BMC Complementary and Alternative Medicine 2010 10:1 doi:10.1186/1472-6882-10-1 |
||||
